Narrative review / 2012
Review notes studies indicating blood pressure reductions following quercetin supplementation in hypertensive animals and humans.
This review evaluates evidence on quercetin's potential therapeutic role and blood pressure-lowering mechanisms. The authors note that work in hypertensive animals and humans (>140 mm Hg systolic and >90 mm Hg diastolic) indicates a decrease in blood pressure after quercetin supplementation. Proposed mechanisms include antioxidant effects, inhibition of angiotensin-converting enzyme activity, and improved endothelial function, though most mechanisms have been identified in animal models and relatively few have been corroborated in humans.
- Study type
- Review
- Who was studied
- Hypertensive animals and humans (>140 mm Hg systolic and >90 mm Hg diastolic)
- What was measured
- Blood pressure and potential mechanisms
THE PAPER
Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms.
Larson AJ, Symons JD, Jalili T. Adv Nutr, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.